Looking for Free Legal Representation for Government Reimbursement on Cannabis Products? RYAH Medtech’s Got Your Back
Ryan Allway
August 21st, 2019
App, Exclusive, News, Top News
Even with medical marijuana being legal in Canada for years, regulations are still a bird’s nest being untangled to this day. There are practical limits and issues that consumers must deal with regularly to receive government reimbursement that often times require the assistance of a professional skilled in the process.
RYAH Medtech Inc. recognizes this fact and is getting proactive on the matter, recently joining forces with soscannabis.com, a law firm specializing in helping people that use doctor-prescribed medical cannabis to seek retroactive and prospective monetary reimbursement through claims made to governmental organizations.
RYAH and SOS Cannabis
RYAH is positioned at the intersection of medical plant intake, high tech and big data. The company has developed and is now commercializing the world’s first dose-measuring vaporizer that allows patients to precisely and automatically track and control how much cannabis (or any other plant) they inhale through the vaporizer, collecting and sharing the HIPAA-compliant data with their physician.
Through an associated application, the patient automatically has a full data set about the exact strain, heating, dosage and effects. Armed with this information, the patient can then work with a doctor about making informed adjustments to dial-in a personalized prescription to achieve the desired benefit in a way that replaces antiquated paper documentation.
By aggregating the data and using artificial intelligence, RYAH is seeking to build the most robust library of every medical plant life cycle in the industry for predictive analysis. Beyond the patient and doctor, the data has meaningful applications for growers, dispensaries and licensed processors to monitor and manage cannabis strains and the effect it has on different patients.
Click Here for Additional Investor Information and Corporate Updates
From its headquarters in Quebec, SOS Cannabis is more than just a seasoned multi-disciplinary law firm with expertise in medical cannabis reimbursement. The company also provides referral services to a network of doctors and medical cannabis suppliers.
The Partnership
There are strong synergies between SOS Cannabis and RYAH to ensure patients are getting the cannabis that they need for their malady and being properly reimbursed. Per the new pact, Canadian patients will have the opportunity to obtain free legal representation from SOS Cannabis for pursuing reimbursement from different government agencies for purchasing RYAH’s Health Canada Class I dose-measuring vaporizer and proprietary dry-herb cartridges.
In June, RYAH entered the Canadian markets, signing a distribution agreement with licensed producer Northern Green Canada to put the eponymous vaporizers and cartridges on shelves across the country.
Through the partnership with SOS Cannabis, Canadian patients using the RYAH products will be able to look to SOS Cannabis to prepare a case file and seek reimbursement at no cost. The relationship is expected to widen RYAH’s Canadian footprint to provide doctors and patients a complete solution and the company a unique opportunity to bridge what can be a challenging barrier to market entry.
Click Here for Additional Investor Information and Corporate Updates
“RYAH’s focus on providing patients with a world-class dose-measuring, strain analytics and real-time feedback capability is much needed in the plant-based medical arena,” said Maitre Robert Astell, President of SOS Cannabis, in a statement about the new partnership.
Mr. Astell continued, “We look forward to onboarding RYAH consumers into our fully-automated registration platform and to provide them with a state-of-the-art case management service in fulfilling their need for economic assistance in providing cannabis-based medicine products.”
RYAH Coming Public
Based in New York City, RYAH is extending its market presence throughout Canada and the U.S., recently placing its product in retail locations in Oklahoma, Washington and Maryland. The accord with Northern Green Canada also opens the door to European markets through Northern Green’s distribution channels there. RYAH received its CE Mark for European commercialization in June, 2019.
The company is in the process of joining the public domain on the Canadian Securities Exchange with the ticker “RYAH” currently pending as the documentation is finalized for a reverse takeover of Prime Blockchain Inc. RYAH is bringing a comprehensive medtech solution that the company believes is filling a gaping void in healthcare to personalize cannabis prescriptions.
Click Here for Additional Investor Information and Corporate Updates
To Stay Up to Date with Ryah Click Here
For Additional Information on soscannabis.com click here
Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry.
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD (“health & wellness” line), and secondly, its unique DermSafe® hand sanitizer; all made with its patented Invisicare® skin delivery technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
